When New Zealand dog owners research flea treatment, two products consistently lead the discussion: Bravecto and NexGard. Both are oral chewables. Both are veterinary-recommended with strong clinical evidence. Both are available through authorised retailers across New Zealand. The choice between them is not straightforward in the way that choosing between an effective and an ineffective product would be — both are effective. The decision comes down to which better fits the specific dog, the specific household, and the specific parasite management requirements. Bravecto flea treatment NZ and NexGard approach the same core need through meaningfully different product designs.
Duration: The Most Consequential Difference
Bravecto provides twelve weeks of flea and tick protection from a single oral dose. NexGard requires monthly dosing — twelve doses per year compared to Bravecto's four. This difference in dosing frequency is the single most consequential distinction between the products for most dog owners. For those who want to minimise administration frequency and reduce the annual number of treatment events, Bravecto's quarterly schedule is a meaningful advantage. For those who prefer a monthly rhythm — perhaps because the monthly administration prompts a health check routine for their dog — NexGard's monthly schedule is not a disadvantage but a different feature.
The compliance argument favours less frequent dosing in theory: four opportunities per year to miss a dose is better than twelve. In practice, both products are used consistently by owners with good reminder systems. The question is which schedule fits naturally into the existing rhythms of the household. Owners with monthly routines that can anchor a treatment event will do well with NexGard. Owners who find monthly anything difficult to maintain will do better with Bravecto's quarterly schedule.
Coverage: What Each Product Addresses
Standard NexGard covers fleas and ticks. NexGard Spectra extends this to heartworm, roundworm, hookworm, and whipworm — making it a comprehensive single-product option in a monthly chew. Standard Bravecto covers fleas and ticks but not internal parasites. Bravecto Plus for cats adds roundworm and ear mite coverage. For dogs in heartworm risk areas of New Zealand — the northern North Island — NexGard Spectra offers a more complete coverage profile from a single product. For dogs in lower-risk areas or on separate internal parasite treatment, the external parasite coverage of Bravecto and standard NexGard is equivalent.
Neither standard NexGard nor standard Bravecto covers tapeworms. Dogs that hunt or have persistent flea exposure — fleas transmit Dipylidium caninum tapeworms through the grooming-ingestion route — may benefit from periodic additional tapeworm treatment regardless of which primary product they are on. This is typically an annual addition rather than a monthly requirement for most New Zealand dogs.
Speed of Action
NexGard begins killing fleas within four hours of dosing and achieves greater than ninety-nine percent flea elimination within twenty-four hours. Bravecto achieves comparable results within twelve hours. The practical difference in onset for most clinical situations is minimal — both products work within the same day of administration. For dogs with severe existing flea burdens where rapid relief is a priority, the four-hour onset of NexGard is a modest advantage, but both products will substantially reduce the existing burden within the first twenty-four hours.
Water Exposure and Lifestyle Fit
Both Bravecto chewable and NexGard are oral treatments, meaning water exposure has no effect on either product's efficacy. Swimming, bathing, and rain do not compromise protection because the active compound is in the dog's bloodstream, not on the coat surface. This shared characteristic is a meaningful advantage over topical treatments for New Zealand dogs with active outdoor and water lifestyles.
Cost and Purchasing
On a per-month equivalent basis, Bravecto and NexGard are broadly comparable in cost, with variation by retailer and formulation size. Both require a current veterinary prescription and are available from authorised pet supply NZ online retailers at lower prices than veterinary clinic retail. For multi-dose purchasing — three-month NexGard packs or two-dose Bravecto packs — both products offer per-dose savings over single-dose purchasing.
The Final Recommendation for Most NZ Dogs
For most New Zealand dog owners outside heartworm risk areas, Bravecto and NexGard are genuinely equivalent choices for flea and tick control. The decision comes down to dosing frequency preference. If you want quarterly simplicity and the pet swims actively, Bravecto. If you want monthly comprehensive coverage including internal parasites, NexGard Spectra. Both are proven, both are recommended, and both are available from authorised
pet supply NZ
retailers with a valid prescription. The best product is the one that gets used consistently — pick the one that best fits your household rhythm and stick with it.
Getting the Right Product for Your New Zealand Pet
New Zealand pet owners have access to a well-regulated market of veterinary parasite prevention products that has improved significantly in both breadth and accessibility over the past decade. The combination of prescription-only status for the most effective treatments — ensuring veterinary oversight — and the growth of authorised online retailers — ensuring competitive pricing — means that effective, consistent parasite prevention is both medically supported and economically accessible.
The practical framework for most New Zealand pet owners is straightforward: establish the appropriate product for your specific animal at the annual veterinary check-up, obtain the prescription, and source the year's supply from an authorised pet supply NZ retailer. Maintain the schedule consistently using whatever reminder system works reliably for your household, treat all animals in the household simultaneously, and include environmental management when addressing any existing infestation. This approach provides the best possible parasite protection for your pet without unnecessary complexity or cost.
When to Review Your Current Approach
Parasite management should be reviewed at any annual veterinary check-up, any time a pet changes weight significantly enough to affect its weight-range formulation, any time a new pet joins the household and requires integration into the existing programme, and any time a product appears to be failing — whether through apparent treatment failure, unexpected adverse effects, or a change in the pet's health circumstances that might create new product considerations.
The New Zealand veterinary profession is well-informed about local parasite prevalence, regional heartworm risk, and the evidence base for current product recommendations. Your local vet's advice is more specifically relevant to your area and your individual animal than any general information source — including this one. Use annual check-ups as the opportunity to validate that your current approach remains appropriate, and use authorised pet supply NZ retailers for cost-efficient routine supply between those annual reviews.